LoPriore Vincent S
Executive Chairman
LoPriore Vincent S has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.
On the most recent filing, LoPriore Vincent S is listed as Executive Chairman at Hepion Pharmaceuticals, Inc. Inside the rolling window, LoPriore Vincent S reported 2 open-market purchases totaling $750K in HEPA and no open-market sales. The largest disclosed transaction in the window is a purchase of 10,000,000 HEPA shares on Aug 3, 2026, worth $500K.
Companies traded
Other insiders at HEPA
Insider Buying
$750K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has LoPriore Vincent S made?
LoPriore Vincent S has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does LoPriore Vincent S trade?
LoPriore Vincent S has filed SEC Form 4 disclosures for 1 company, including HEPA.
When was LoPriore Vincent S's most recent SEC Form 4 filing?
LoPriore Vincent S's most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.
What is LoPriore Vincent S's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, LoPriore Vincent S is listed as Executive Chairman.
What is LoPriore Vincent S's total buy and sell value in the current window?
Inside the rolling retention window, LoPriore Vincent S bought $750K and sold $0 based on SEC Form 4 filings.
What was LoPriore Vincent S's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000,000 HEPA shares on 2026-08-03, worth $500K, per SEC Form 4 filings.